NEUROLOGICAL AUTOIMMUNE DISEASES
Clinical trials for NEUROLOGICAL AUTOIMMUNE DISEASES explained in plain language.
Never miss a new study
Get alerted when new NEUROLOGICAL AUTOIMMUNE DISEASES trials appear
Sign up with your email to follow new studies for NEUROLOGICAL AUTOIMMUNE DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell shot aims to tame Out-of-Control nerve attacks
Disease control Recruiting nowThis early-phase study tests a new cell therapy called CNCT19 in 18 adults with severe autoimmune nerve diseases that have not responded to standard treatments. The therapy targets and removes certain immune cells (CD19+ B cells) that are attacking the nervous system. The main go…
Matched conditions: NEUROLOGICAL AUTOIMMUNE DISEASES
Phase: EARLY_PHASE1 • Sponsor: Juventas Cell Therapy Ltd. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New cell therapy targets Hard-to-Treat brain and nerve disorders
Disease control Recruiting nowThis early-stage study tests a new treatment called GT719 for people with severe neurological autoimmune diseases that have not responded to other therapies. The treatment uses specially designed cells to target the immune system's attack on the nerves. The study will check if th…
Matched conditions: NEUROLOGICAL AUTOIMMUNE DISEASES
Phase: PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Blood filtering tested for nerve disease relief
Disease control Recruiting nowThis study observes how well therapeutic plasma exchange (a procedure that filters the blood) works for people with autoimmune neurological diseases. About 60 Egyptian patients will be followed to see if their symptoms and daily function improve. The goal is to understand if this…
Matched conditions: NEUROLOGICAL AUTOIMMUNE DISEASES
Sponsor: Al-Azhar University • Aim: Disease control
Last updated May 14, 2026 12:03 UTC